These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 23046147)
1. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. Sand PK; Dmochowski RR; Reddy J; van der Meulen EA J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. Weiss JP; Herschorn S; Albei CD; van der Meulen EA J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402 [TBL] [Abstract][Full Text] [Related]
5. Long-term durability of the response to desmopressin in female and male nocturia patients. Juul KV; Klein BM; Nørgaard JP Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development program. Yamaguchi O; Juul KV; Falahati A; Yoshimura T; Imura F; Kitamura M Low Urin Tract Symptoms; 2020 Jan; 12(1):8-19. PubMed ID: 31397969 [TBL] [Abstract][Full Text] [Related]
7. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. van Kerrebroeck P; Rezapour M; Cortesse A; Thüroff J; Riis A; Nørgaard JP Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773 [TBL] [Abstract][Full Text] [Related]
8. Gender difference in antidiuretic response to desmopressin. Juul KV; Klein BM; Sandström R; Erichsen L; Nørgaard JP Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921 [TBL] [Abstract][Full Text] [Related]
9. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin. Fu FG; Lavery HJ; Wu DL Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590 [TBL] [Abstract][Full Text] [Related]
10. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia. Juul KV; Malmberg A; van der Meulen E; Walle JV; Nørgaard JP BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898 [TBL] [Abstract][Full Text] [Related]
11. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Rovner ES; Raymond K; Andruczyk E; Juul KV Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762 [TBL] [Abstract][Full Text] [Related]
12. Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria. Weiss JP; van der Meulen EA; Juul KV Eur Urol Focus; 2020 Sep; 6(5):1006-1012. PubMed ID: 30470646 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of desmopressin in women with nocturia: a systematic review and meta-analysis of randomized controlled trials. Cai X; Tian Y; Nie M; Wang K Int Urol Nephrol; 2019 Nov; 51(11):1913-1923. PubMed ID: 31352583 [TBL] [Abstract][Full Text] [Related]
14. Re: gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. Griebling T J Urol; 2013 Aug; 190(2):622. PubMed ID: 23845356 [No Abstract] [Full Text] [Related]
15. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men. Ho DR; Lin WY; Wu CF; Shee JJ; Huang YC; Chen CS BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study. Arima H; Oiso Y; Juul KV; Nørgaard JP Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987 [TBL] [Abstract][Full Text] [Related]
17. Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion. Goldberg H; Baniel J; Mano R; Gillon G; Kedar D; Yossepowitch O BJU Int; 2014 Nov; 114(5):727-32. PubMed ID: 24314054 [TBL] [Abstract][Full Text] [Related]
18. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study. Bae JH; Oh MM; Shim KS; Cheon J; Lee JG; Kim JJ; Moon DG J Urol; 2007 Jul; 178(1):200-3. PubMed ID: 17499799 [TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. Schulman SL; Stokes A; Salzman PM J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804 [TBL] [Abstract][Full Text] [Related]
20. Desmopressin for treating nocturia in men. Han J; Jung JH; Bakker CJ; Ebell MH; Dahm P Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012059. PubMed ID: 29055129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]